Claims
- 1. 2-Chloro-12-(3-dimethylamino-2-methylpropyl)-12H-dibenzo[d,g][1,3,6]dioxazocine in optically active form or a pharmaceutically acceptable acid addition salt thereof.
- 2. (+)-2-Chloro-12-(3-dimethylamino-2-methylpropyl)-12H-dibenzo[d,g][1,3,6]dioxazocine or a pharmaceutically acceptable acid addition salt thereof.
- 3. (-)-2-Chloro-12-(3-dimethylamino-2-methylpropyl)-12H-dibenzo[d,g][1,3,6]dioxazocine or a pharmaceutically acceptable acid addition salt thereof.
- 4. A pharmaceutical composition for treating Parkinson's disease comprising 2-chloro-12-(3-dimethylamino-2-methylpropyl)-12H-dibenzo[d,g][1,3,6]dioxazocine in optically active form or a pharmaceutically acceptable acid addition salt thereof and one or more pharmaceutical carrier(s).
- 5. A method of treating Parkinson's disease which comprises administering to a mammolian subject a therapeutically effective amount of an optically active 2-chloro-12-(3-dimethylamino-2-methylpropyl)-12H-dibenzo[d,g][1,3,6]dioxazocine or a pharmaceutically acceptable acid addition salt thereof.
Priority Claims (1)
Number |
Date |
Country |
Kind |
4881/85 |
Dec 1985 |
HUX |
|
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part of Ser. No. 921,672 filed 10-21-86, now abandoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4208410 |
Rozsa et al. |
Jun 1980 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
921672 |
Oct 1986 |
|